Preleukemia
Information
- Disease name
- Preleukemia
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT02158858 | Active, not recruiting | Phase 1/Phase 2 | A Phase 2 Study of CPI-0610 With and Without Ruxolitinib in Patients With Myelofibrosis | July 16, 2014 | October 31, 2024 |
| NCT00943592 | Completed | Phase 1/Phase 2 | Clofarabine-Melphalan-Alemtuzumab Conditioning in Patients With Advanced Hematologic Malignancies | March 2006 | November 2013 |
| NCT03066648 | Completed | Phase 1 | Study of PDR001 and/or MBG453 in Combination With Decitabine in Patients With AML or High Risk MDS | July 6, 2017 | September 8, 2023 |
| NCT04741945 | Recruiting | Phase 2 | Repurposing Metformin as a Leukemia-preventive Drug in CCUS and LR-MDS | December 13, 2021 | June 2026 |
| NCT00943293 | Terminated | Phase 1 | Minor Histocompatibility Vaccination After Allogeneic Stem Cell Transplantation for Advanced Hematologic Malignancies | May 2003 | January 2012 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D011289